HURA

NASD TuHURA Biosciences, Inc.
Oct 2, 2026 · 2:50 PM ET DELAYED Market Open

$1.93 ↓ -0.05 (-2.78%) Trading Down from the previous close of $1.98, $0.12 below the day’s high of $2.05

YTD change
+154.39%
vs 20-day SMA
-7.34%
vs 200-day SMA
+4.00%

Price ranges

Previous day
$1.97 $2.10
open $2.09 close $1.98
-$0.11 (-5.26%)
Today
$1.88 $2.05
open $2.00 now $1.93
-$0.08 (-3.75%)
Past week
$1.97 $2.18
from $2.10 now $1.93
-$0.18 (-8.33%)
Past month
$1.97 $2.22
from $2.09 now $1.93
-$0.17 (-7.89%)
This year
$0.41 $3.43
from $0.76 now $1.93
+$1.17 (+154.39%)

Price & Performance

+0.57 (+40.43%) / 6M

$1.27$1.94$2.62$3.29Apr 2Jul 2Oct 1

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Poor
  • The stock is 75.7% away from all-time highs of $7.93
  • HURA is up 154% since the beginning of the year
  • HURA is down 26% over the past 12 months
  • HURA is down 8% over the past 1 month
  • 14% of all HURA investors are betting against HURA

HURA reads poor: price sits above one of the two key moving averages, the 12-month move is -24.1%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.14
Earnings momentum -3.7% Quarterly EPS growth
Quarterly change -3.7%

Valuation

P/E ratio N/A
Enterprise value $129.9M
Beta -1.02

Balance sheet & scale

IncomeN/A
RevenueN/A
Cash$996.0K
Debt$4.0K
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Professional, Scientific, and Technical Services
Industry Group Scientific Research and Development Services
Market cap $126.6M

TuHURA Biosciences, Inc. is a clinical-stage immuno-oncology company, which engages in the development of novel technologies to overcome resistance to cancer immunotherapy. Its lead product candidate, IFx2.0, is an innate immune agonist designed to overcome primary resistance to checkpoint inhibitors. The company was founded by Michael Lawman, Patricia Lawman and James A. Bianco on May 4, 2023 and is headquartered in Tampa, FL.

Competitor comparison

TickerCompany PriceChange
AMGN Amgen Inc. $407.27 -3.38%
MRNA Moderna, Inc. $188.94 -1.89%
RVMD Revolution Medicines, Inc. $205.89 +0.31%
ROIV Roivant Sciences Ltd. $35.50 -2.93%
BNTX BioNTech SE Sponsored ADR $96.85 -1.48%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.